Vaccine composition containing adjuvants

Details Vaccine composition containing adjuvants Vaccine composition containing adjuvants

2006-12-12

2006-12-12

Parkin, J. S. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S278100, C424S283100

Reexamination Certificate

active

07147862

ABSTRACT:
The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and γ IFN responses.

REFERENCES:
patent: 4877611 (1989-10-01), Cantrell
patent: 4912094 (1990-03-01), Myers et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5750110 (1998-05-01), Prieels et al.
Schofield, et al, 1987, “γ Interferon, CD8+T Cells and . . . ” Nature 330:664-666.
Long, et al, 1984, “Glycoprotein D Protects Mice Against . . . ” Infect & Imm. 37(2): 761-764.
Schneerson, et al, 1991, “Evaluation of Monophosphoryl . . . ” J. Immunol. 147(7): 2136-2140.
Weiss, et al, 1988, “CD8+T Cells . . . ” PNAS 85, 573-576.
Butini, et al, 1994, “Comparative Analysis of HIV-Specific . . . ” Abstract J306, J. Cell. Biochem, Suppl. 18 B.
Cohen, 1993, “Jitters Jeopardize AIDS . . . ” Science 262: 980-981.
Fahey et al.,Clin. Exp. Immunol.88:1-5, 1992.
Fox., J.L.,Bio/Technology12:128, Feb. 1994.
Haynes et al.,Ann. Med.28:39-41, 1996.

Affiliated with

Also associated with

Rating

Vaccine composition containing adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine composition containing adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition containing adjuvants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3667583